View online Forward to a friend   |   Facebook   |   Twitter
Pharmaceutical Outsourcing
Featured Articles   |   Featured Partners   |   Videos   |   Service Listings   |   Industry News   |   Events
June 11, 2019
learn more
Newsletter Sponsor
   Metrics Contract Services Continues Strong Focus on FTIM and Phase I Services

For over 20 years, Metrics has been growing and expanding capacities, capabilities, and manufacturing processes for small molecule oral solid dosage forms. Today we want to remind our clients and the industry that we have not lost our focus on where it all began. Metrics continues to invest in equipment and resources to support a healthy foundation of business in the First-time-in-Man/Phase I space. Visit metricscontractservices.com and learn more about how we can support your next project.

more info

» Industry News
 
more news
» Featured Articles
Oral Solid Dosage Manufacturing Roundtable
Many issues that the pharmaceutical drug development industry face not only affect oral solid dose manufacturing and one of the constant challenges is the scalability of new molecules emerging from ... read more »
The Impact of Nano-Technology on Biologic Drug Development
Biologics have unique developmental challenges on their pathway to becoming a commercial product. Today’s biologics are developed utilizing a wide variety of modalities, including antibodies, peptides... read more »
more articles
 
» Featured Partners
learn more
  [Webinar] Pharmaceutical Development of Oligonucleotides

Oligonucleotides are an emerging class of DNA and RNA therapeutics that address a number of unmet medical needs. As with many biopharmaceuticals, the complex structure of oligonucleotides makes their large-scale synthesis both challenging and imperfect. A number of impurities are generated during manufacturing, many of which are hard to identify using available analytical methods. Furthermore, the... read more »
» Featured Video
learn more
  Watch Video: A Discussion with Andy Topping, PhD CSO from Fujifilm Diosynth Biotechnologies
Watch Video: A Discussion with Andy Topping, PhD CSO from Fujifilm Diosynth Biotechnologies read more »
learn more
  Watch Video: Liza Rivera from Fujifilm Diosynth Biotechnologies discusses Outreach
Watch Video: Liza Rivera from Fujifilm Diosynth Biotechnologies discusses Outreach read more »

more videos
 
» Featured Whitepaper
Considerations for Development of a Lyophilized Biosimilar
The patents for a number of parental biologic formulations are destined to expire in the United States between 2016 and 2027. This provides ... read more »
Proceed With Confidence. Understanding Your Molecule’s Full Potential During Proof of Concept
Demonstrating your molecule's proof-of-concept (PoC) is an important developmental milestone. If you can show compelling and valid data supporting ... read more »
more articles
 
| Events
EVENT
  DIA 2019 Global Annual Meeting
San Diego, CA –  06/23/2019
The DIA 2019 Global Annual Meeting is more than just a meeting: it’s where brilliant minds come together to create solutions. Thousands of global ... event details »
EVENT
  Clinical Operations in Oncology Trials East Coast 2019
Cambridge, MA –  07/10/2019
The Clinical Operations in Oncology Trials (CTO) meeting returned to Boston for its 6th year with over 150 attendees from biopharmaceutical, medical ... event details »
more events
This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription |  Unsubscribe  | Contact Pharmaceutical Outsourcing


Pharmaceutical Outsourcing
164 Townsend St. Unit 2
San Francisco, CA 94107 USA